Prosecution Insights
Last updated: October 02, 2026
Application No. 18/734,110

GENERATING RECOMMENDATIONS FOR VENTILATION

Final Rejection §112
Filed
Jun 05, 2024
Priority
Jul 25, 2023 — CN PCT/CN2023/109178 +1 more
Examiner
LEWIS, CAMRYN BROOKE
Art Unit
3683
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Koninklijke Philips N.V.
OA Round
4 (Final)
5%
Grant Probability
At Risk
5-6
OA Rounds
4m
Est. Remaining
16%
With Interview

Examiner Intelligence

Grants only 5% of cases
5%
Career Allowance Rate
1 granted / 20 resolved
-47.0% vs TC avg
Moderate +11% lift
Without
With
+11.1%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
15 currently pending
Career history
51
Total Applications
across all art units

Statute-Specific Performance

§101
42.7%
+2.7% vs TC avg
§103
35.9%
-4.1% vs TC avg
§102
8.8%
-31.2% vs TC avg
§112
12.5%
-27.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 20 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Response to Amendment In the Amendment dated 21 May 2026, the following occurred: Claim 14 was canceled. Claims 1-3, 5-13, and 15 are pending. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1-3, 5-13, and 15 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claims 1 and 15 (Claim 1 being representative) contain subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. This is a new matter rejection. Claim 1 recites: controlling the ventilation system to operate according to the one or more recommended values The specification (including cited Para. 102, 119, 125, 129, and 132) is devoid of any description of the computer controlling the ventilator, evidencing that the Applicant did not have possession of the invention at the time of filing. In fact, at multiple locations the specification describes a person (clinician/end user) implementing the recommendations (Page 6, Line 35-37; Page 18, Line 5-6, 9-10). By virtue of their dependence from Claim 1, this basis of rejection also applies to dependent Claims 2, 3, and 5-13. Response to Arguments Rejection under 35 U.S.C. § 112 Regarding the written description rejection of Claims 1-3, 5-13, and 15, the Examiner has considered the Applicant’s arguments; however, the arguments are not persuasive. Applicant argues: …even if the clinician does input or change a ventilator setting, the clinician is not actually controlling the ventilator to implement those settings—the computer is. Regarding (a), the Examiner respectfully disagrees. If the clinician is inputting or changing a ventilator setting, they are using the computer as a tool to achieve the described result. The specification does not have to say, in the exact terms, that “the ventilator applies computer control to set or update ventilation settings”—automatically or otherwise—to meet the § l12(a) disclosure obligations. Regarding (b), the Examiner respectfully agrees. However, the rejection is not based on the absence of the exact recited terminology. The Specification must provide adequate written description support for the claimed limitation. The Specification does not demonstrate possession of a computer-controlled ventilation system. Accordingly, Applicant’s argument does not overcome the rejection. The Office Action seems to read the claims as being limited only to automatic (closed-loop) control of the ventilator with no human interaction whatsoever… this is not warranted by the text of the claims, which recite a step of “control[ling] the ventilation system to operate according to the one or more recommended values”—automatically or after a clinician enters it. Regarding (c), the Examiner respectfully disagrees. Interpreting that the ventilator is controlled automatically by the computer without human interaction is the distinction that allowed the claims to be considered subject matter eligible. The computer-controlled ventilation functionality is the technological application relied upon in the eligibility analysis, but the Specification must actually disclose that functionality to support the claim under § l12(a). Applicant’s argument further supports Examiner’s original assertion that the Specification does not describe a computer-controlled ventilation system, and instead relies on clinician intervention. Conclusion Prior art made of record though not relied upon in the present basis of rejection are noted in the attached PTO 892 and include: Palit et al. (U.S. 2017/0091789) which discloses systems and methods for calibrating user and consumer data. Vasudevan et al. (U.S. 2021/0375437) which discloses systems and methods for discharge evaluation triage. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CAMRYN B LEWIS whose telephone number is (703)756-1807. The examiner can normally be reached Monday - Friday, 11:00 am - 8:00 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert W Morgan can be reached on 571-272-6773. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CAMRYN B LEWIS/ Examiner, Art Unit 3683 /ROBERT W MORGAN/Supervisory Patent Examiner, Art Unit 3683
Read full office action

Prosecution Timeline

Show 2 earlier events
Nov 06, 2025
Response Filed
Dec 04, 2025
Final Rejection mailed — §112
Dec 08, 2025
Response after Non-Final Action
Feb 16, 2026
Request for Continued Examination
Feb 19, 2026
Response after Non-Final Action
May 18, 2026
Non-Final Rejection mailed — §112
May 21, 2026
Response Filed
Aug 24, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12412667
NON-INVASIVE GLYCATED HEMOGLOBIN OR BLOOD GLUCOSE MEASUREMENT SYSTEM AND METHOD WHICH USE MONTE CARLO SIMULATION
1y 8m to grant Granted Sep 09, 2025
Patent 12278008
THERAPEUTIC SYSTEM AND METHOD FOR TEACHING SOCIAL OR EMOTIONAL MANAGEMENT SKILLS TO A PATIENT
2y 2m to grant Granted Apr 15, 2025
Study what changed to get past this examiner. Based on 2 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
5%
Grant Probability
16%
With Interview (+11.1%)
2y 8m (~4m remaining)
Median Time to Grant
High
PTA Risk
Based on 20 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month